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Abstract
MT1-MMP is a potent invasion-promoting membrane protease employed by aggressive cancer cells. MT1-MMP localizes
preferentially at membrane protrusions called invadopodia where it plays a central role in degradation of the surrounding
extracellular matrix (ECM). Previous reports suggested a role for a continuous supply of MT1-MMP in ECM degradation.
However, the turnover rate of MT1-MMP and the extent to which the turnover contributes to the ECM degradation at
invadopodia have not been clarified. To approach this problem, we first performed FRAP (Fluorescence Recovery after
Photobleaching) experiments with fluorescence-tagged MT1-MMP focusing on a single invadopodium and found very rapid
recovery in FRAP signals, approximated by double-exponential plots with time constants of 26 s and 259 s. The recovery
depended primarily on vesicle transport, but negligibly on lateral diffusion. Next we constructed a computational model
employing the observed kinetics of the FRAP experiments. The simulations successfully reproduced our FRAP experiments.
Next we inhibited the vesicle transport both experimentally, and in simulation. Addition of drugs inhibiting vesicle transport
blocked ECM degradation experimentally, and the simulation showed no appreciable ECM degradation under conditions
inhibiting vesicle transport. In addition, the degree of the reduction in ECM degradation depended on the degree of the
reduction in the MT1-MMP turnover. Thus, our experiments and simulations have established the role of the rapid turnover
of MT1-MMP in ECM degradation at invadopodia. Furthermore, our simulations suggested synergetic contributions of
proteolytic activity and the MT1-MMP turnover to ECM degradation because there was a nonlinear and marked reduction in
ECM degradation if both factors were reduced simultaneously. Thus our computational model provides a new in silico tool
to design and evaluate intervention strategies in cancer cell invasion.
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Introduction
Some matrix metalloproteinases (MMPs) are proinvasive and
employed by motile and invasive cells to degrade extracellular
matrix (ECM). Among the 23 MMPs in mammals, integral
membrane type MMPs, especially MT1-MMP, are believed to
provide major contributions to cancer cell invasion. In fact,
specific inhibition of MT1-MMP activity or knockdown of its
expression suppresses not only cancer cell invasion in vitro but also
tumor growth in mice [1,2,3,4]. Therefore, MT1-MMP must be
an important component of the cellular invasion machinery, and
indeed, active ECM degradation is produced at structures called
invadopodia [5,6], which are specialized membrane protrusions
extending into the ECM. Thus, invadopodia are hypothesized as
machinery to degrade ECM at the initial stage of cancer cell
invasion.
MT1-MMP was reported to be enriched in invadopodia [7,8,9].
In addition, the accumulation of MT1-MMP in invadopodia was
followed by the degradation of ECM at the same sites [8]. These
observations indicate that MT1-MMP plays a crucial role in ECM
degradation at invadopodia [10]. However, the ECM-degrading
activity of MT1-MMP will not be persistent, because cell-surface
MT1-MMP is inactivated by TIMP-2 which is an endogenous
MT1-MMP inhibitor that inhibits the proteolytic degradation of
ECM. Therefore, a continuous supply of active MT1-MMP to the
surface seems to be critical for maintaining ECM degrading [11].
Several reports have been published that support the impor-
tance of a continuous supply of MT1-MMP. It is reported that
MT1-MMP is delivered to the invasion front of cells by vesicle
transport in a 3D collagen matrix [12]. MT1-MMP is delivered to
invadopodia by the exocyst complex, and the process is regulated
by cortactin, IQGAP1 and RhoA [8,13]. VAMP7, a member of
the v-snare protein family, also regulates MT1-MMP transport to
invadopodia, and MT1-MMP appears to be stored in late
endosomal/lysosomal vesicles together with VAMP7 [14].
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internalization of MT1-MMP was also reported [15,16]. MT1-
MMP was colocated with clathrin, and the internalization
proceeded through a clathrin-dependent pathway [16,17,18] or
in a caveolae-mediated manner[19,20]. Inhibition of caveolin-1 by
siRNA was shown to block the MT1-MMP-dependent ECM
degradation [21].
All these previous reports strongly suggest a crucial role of a
continuous supply and internalization of surface MT1-MMP (i.e.
the turnover of MT1-MMP), particularly by vesicle-mediated
mechanisms. However, the turnover rate of MT1-MMP and the
extent to which the turnover contributes to ECM degradation at
invadopodia have not been clarified. In the present study, we
attempted to measure experimentally the turnover rate of MT1-
MMP at a single invadopodium, and to elucidate the role of the
turnover in ECM degradation by computer simulations.
First, we analyzed the turnover rate of MT1-MMP at a single
invadopodium by FRAP (Fluorescence Recovery after Photo-
bleaching) experiments using a chimeric MT1-MMP with a pH-
sensitive GFP protein (pHLuorin). The recovery of fluorescence
was plotted in a double-exponential plot, which showed time
constants of 26.0 s and 259 s. Based on these experiments, we
constructed a computational model to analyze the role of the rapid
MT1-MMP turnover. Simulations showed no appreciable ECM
degradation when the rapid turnover was inhibited in our
simulation experiments. This was also true in the actual
experiments. In addition, simulations have shown a decrease in
the ECM degradation concomitantly with an increased reduction
of the turnover rate of MT1-MMP. Thus, we have quantified the
rate of turnover of MT1-MMP at single invadopodia and shown
its critical role in ECM degradation both experimentally and by
computer simulations. Furthermore, our simulations have shown a
synergetic effect on the inhibition of ECM degradation by
simultaneous reductions of the MT1-MMP turnover rate and
the vesicular content of it. Our computational model provides a
new in silico tool to design and evaluate intervention strategies in
cancer cell invasion.
Results
Vesicular transport is required for ECM degradation at
invadopodia
Head and neck squamous cell carcinoma SCC61 cells express
endogenous MT1-MMP (Figure 1A). Invadopodia’s ECM-
degrading activity was evaluated by incubating the cells on glass
coated with Dylight 633-labeled fibronectin over cross-linked
gelatin. ECM degradation was observed as dark spots in the
fluorescent ECM layer (Figure 1B). Invadopodia are visualized as
actin puncta located in the ECM degradation spots. As previously
reported, ECM degradation indeed depends on expression of
MT1-MMP, as knockdown of MT1-MMP, using different shRNA
sequences, also abolished the invadopodia-mediated ECM degra-
dation (Figure 1B and C). Therefore, we employed this cell line to
analyze MT1-MMP localization and turnover at invadopodia.
To visualize live-dynamics of MT1-MMP on the plasma
membrane, we employed phLuorin-tagged MT1-MMP (MT1-
Luo). The phLuorin, a pH-sensitive modified GFP, enabled us to
monitor MT1-MMP exposed on the plasma membrane separately
from that in transport vesicles, based on the different pH values in
the compartments [22]. MT1-Luo was stably expressed in SCC61
cells, and those cells, expressing it at a similar level to that of the
endogenous MT1-MMP, were used for experiments. MT1-MMP
represented by MT1-Luo indeed co-localized to invadopodia
(Figure 1D). Fibronectin was labeled with Dylight 633, actin with
Rhodamine-phalloidin. When the degradation spots were ob-
served closer in the picture, it was of particular interest to note that
MT1-Luo co-localized with actin as well, and that they appear to
be surrounding degradation spots (Figure 1D).
MT1-MMP is thought to be supplied to invadopodia contin-
uously by exocytosis. In order to test various transport pathways to
invadopodia, we used bafilomycin A1, which inhibits lysosome
function by inhibiting vacuolar-type H(+)-ATPase (V-ATPase) and
thereby inhibiting the lysosomal vesicle transport pathway;
brefeldin A, which inhibits transport of proteins from ER to the
Golgi system; and dynasore, which inhibits dynamin function and
thereby prevents both endocytosis and trans-Golgi exit [23]. When
cells were treated for 18 hours, all of these inhibitors suppressed
ECM degradation (Figure S1 in Text S1). Bafilomycin inhibited
expansion of the ECM degradation spots almost immediately,
accompanied by increased visibility of intracellular vesicles
because of H increase (Figure 2C and D). These results suggest
that MT1-MMP is supplied to the invadopodia mainly by
recycling mediated by lysosomes rather than by direct exocytosis
from the Golgi apparatus to the invadopodia.
Invadopodia form distinct membrane area with limited
mobility
The above data indicate that continuous transport of MT1-
MMP into the plasma membrane is critical for maintenance of the
invadopodia’s ECM-degrading activity. However, it is unclear to
what extent lateral diffusion of MT1-MMP contributes to
localization of the protease at invadopodia. To evaluate this
possibility, we monitored fluorescence recovery after photo-
bleaching (FRAP) of MT1-Luo at invadopodia. One-half of an
invadopodium area, indicated by the open box area in region 1 in
Figure 2A, was photo-bleached. To prevent a supply of MT1-Luo
from the cytoplasm to reach the photobleached area by vesicle
transport, we continuously bleached the surrounding area (region
2) (Figure 2A). Most of the cytoplasmic vesicles have to travel
across the bleached ‘‘region 2’’ when they try to reach the
invadopodium. If the membrane mobility of MT1-MMP at
invadopodia were sufficient to allow lateral diffusion of MT1-Luo,
Author Summary
Prevention of invasion is important in cancer therapy. MT1-
MMP is a membrane protein involved in degradation of
ECM (extracellular matrix) that is highly expressed at
invadopodia, which are small protrusions of cancer cells.
ECM degradation by MT1-MMP at invadopodia is hypoth-
esized as the initial step of cancer cell invasion. However,
MT1-MMP is inhibited by the endogenous inhibitor TIMP-2,
so continuous turnover of MT1-MMP at the surface of
invadopodia would be required. In agreement, it has been
reported that the blockade of vesicle transport, which is
one mechanism involved in the turnover, blocked the ECM
degradation. However, the turnover rate of MT1-MMP at
invadopodia and the extent to which the turnover is
critical for the degradation of ECM have not been clarified.
In this report we measured the turnover rate of MT1-MMP
at a single invadopodium and found rapid turnover rates
with time constants of 26 s and 259 s, which primarily
depended on the vesicle transport. A computational
model was constructed based on the observed kinetics.
If we blocked the rapid turnover, the ECM degradation was
blocked both experimentally and in simulations. These
results established the role of the rapid turnover of MT1-
MMP in the ECM degradation at invadopodia.
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bleached area of the same invadopodium. Our results indicated
that there was no fluorescence recovery in the photobleached area
in region 1 during the indicated time period in Figure 2B. Taken
together, these results indicate that lateral diffusion of MT1-Luo
within invadopodia is almost negligible.
Lysosomal secretion regulates quick recycling of MT1-
MMP to invadopodia
Since lateral diffusion is almost negligible in invadopodia, we
then used FRAP to analyze the kinetics of vesicle transport to
invadopodia. Photo-bleaching of MT1-Luo at invadopodia was
60% at 60 sec after having decreased once to 30% of the control
level, but the recovery did not reach 100% even after 330 sec;
instead, it approached a plateau at around 65% (Figure 2D, blue
circles). We observed that FRAP at invadopodia was abrogated by
bafilomycin (Figure 2D, +Baf, pink circles). Thus, quick insertion
of MT1-Luo into the membrane of invadopodia is mostly
mediated by a bafilomycin-sensitive pathway (lysosomal pathway).
Analysis of FRAP experiments revealed two independent
recovery processes at invadopodia
To determine the time constant of fluorescence recovery at
invadopodia, we redrew experimental data in a semi-logarithmic
scale (Figure S2 in Text S1). The recovery was approximated by a
double exponential plot with fast and slow time constants of 26.0
and 259 s, and with the contributions (amplitudes) of 40.7% and
17.5%respectively. The recovery was not complete and reached
an asymptotic level of 41.8%. After the application of bafilomycin,
however, the recovery was approximated by a single time constant
of 49.0 s. Thus, the slow recovery was not observed during the
bafilomycin treatment. These results indicate the existence of two
independent recovery processes for MT1-MMPs at the surface of
invadopodia, and suggest that the slow recovery process is sensitive
to bafilomycin, but the fast one is insensitive to it.
Reconstruction of FRAP experiments
From our experiments and analyses we found that the recovery
of MT1-MMP at invadopodia is composed of two independent
processes. Since the contribution of lateral diffusion of MT1-MMP
within invadopodia was negligible (Figure 2A and B), these
processes are most simply modeled by two surface density-
dependent internalizations of MT1-MMP. However, the slow
process is sensitive to bafilomycin, which blocked the supply of
MT1-MMP from the lysosomal pathway in our experiments.
Therefore, we constructed a model represented by one bafilomy-
cin-sensitive insertion process and one surface density-dependent
internalization process. Thus the model is composed of two pools,
X and D of MT1-MMP at invadopodia with the recovery time
constants of 259 s and 26.0 s, respectively (Figure 3). The observed
fluorescence signal is the sum of the signals from pools X and D. In
pool X, insertion of MT1-MMP depends on the surface density of
MT1-MMP, which was suggested from our experiments (see
below), and internalization takes place at a constant rate. In
contrast, in pool D, insertion takes place at a constant rate, and
internalization depends on the surface density of MT1-MMP.
Our experiment showed that the invadopodial area occupied by
MT1-MMP before bleaching was not refilled completely even at
Figure 1. MT1-MMP is required for invadopodia-related ECM degradation. (A) Protein levels of MT1-MMP were assessed by Western blot
analysis using anti-MT1-MMP antibody. Actin as a loading control. (B) Representative images show Dylight 633-labeled fibronectin (Green) and actin
(Red). (C) Quantification of fibronectin degradation area in Figure 1 B (n=3). (D) Representative images of MT1-Luo localization (Green), actin staining
(Red) and Dylight 633-labeled fibronectin (purple).
doi:10.1371/journal.pcbi.1002479.g001
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newly inserted MT1-MMP resided at a different area in addition
to the area occupied before bleaching. In addition, the
invadopodial area occupied by MT1-MMP did not cover the
whole invadopodial area at any time during the recovery. Thus,
there seemed to be a limited number of sites available for MT1-
MMP insertion in invadopodia (Figure S3 in Text S1). Although
the underlying mechanism for occupying the limited number of
sites at invadopodia is currently not known, this assumption is
consistent with our experiments. Therefore, we assume that there
is a limited number of sites (or docking sites) for MT1-MMP in
pool X. Transported MT1-MMP can be inserted only at free sites
on the membrane.
We derived the following equation for the surface density of
MT1-MMP at invadopodia:
M~MXzMD
~
CDkXz(kXMS{CX)kD
kXkD
{
kX(MS{MX0){CX
kX
e{kXt{
(CD{kDMD0)
kD
e{kDt
ð1Þ
where M is the total amount of MT1-MMP at the region of
interest at an invadopodium, which is the sum of the amounts in
pool D (MD) and pool X (MX) and corresponds to the fluorescence
intensity before photobleaching. CD (kD) and kX (CX) are insertion
(internalization) rate constant for pools D and X, respectively. MS
is the saturated amount of MT1-MMP in pool D, and MD0 and
MX0 are the amounts of unbleached MT1-MMP in pools X and
D, respectively, just after the photobleaching, corresponding to the
fluorescence intensity at t=0. Derivation of Equation 1 and the
parameter values for Eq.1 are shown in Text S1 in detail.
The reconstructed time courses for fluorescence recovery after
photobleaching in the absence and presence of bafilomycin are
shown by continuous curves in Figure 2D. The addition of
bafilomycin was simulated by setting kX at zero. The reconstructed
FRAP signals using Equation 1 represent quite good agreements
with experimental observations. Thus Eq.1 successfully repro-
duced the observations of FRAP experiments. However, the fit
was not complete in the presence of bafilomycin, because, in the
experiments, the time constant of the fast recovery became large
(from 26.0s in the absence of bafilomycin to 49.0 s in the presence
of it) for unknown reasons, which were not considered in the
present model.
Figure 2. MT1-MMP transport to invadopodia via lysosomal secretion. (A) MT1-MMP-phLuorin-expressing SCC61 cells cultured on Dylight
633-labeled fibronectin were subjected to FRAP- continuous photobleaching experiments. One half of the invadopodia area, indicated by the open
box area in region 1, was the FRAP experimental area. Region 2 was a continuous photobleaching area. (B) Quantification of fluorescence recovery in
the Figure 2A FRAP region is calculated. (C) Representative images of FRAP experiments at invadopodia without or with bafilomycin. (D) The recovery
of FRAP signals are shown in the absence (blue circles) and in the presence (pink circles) of bafilomycin. Reconstructed time courses of fluorescence
recovery in the absence (blue line) and in the presence (pink line)of bafilomycin at invadopodia are also shown. The reconstructed FRAP signals show
a good agreement with experimental data.
doi:10.1371/journal.pcbi.1002479.g002
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degradation of ECM
We next constructed a model for the activation of MMP-2 and
the degradation of ECM by MT1-MMP and MMP-2. On the
surface of the invadopodial membrane, MT1-MMP is dimerized,
bound to TIMP-2, and forms a quadruple complex by binding
proMMP-2 (MT1-MMP.MT1-MMP.TIMP-2.MMP-2) as shown
in Figure 4A. proMMP-2 in this complex is processed by TIMP-2-
free MT1-MMP releasing the active form of MMP-2. Active
MMP-2 is inactivated by the binding of TIMP-2.
The state transition diagram of MT1-MMP is shown in
Figure 4B. Here, the insertion (thick arrow) and internalization
(broken-line arrows) of MT1-MMP are also shown. All MT1-
MMP, both TIMP-2-bound and TIMP-2-free, is assumed to be
internalized (small squares). The amount of internalized MT1-
MMP was balanced by the inserted amount. The insertion to pool
D and internalization from pool X were modeled by first order
reaction kinetics, while the internalization from pool D and
insertion to pool X were modeled as constant processes. The
turnover of MT1-MMP by vesicle transport implies the discrete
insertion and internalization processes. If these discrete processes
are averaged over space and time, however, repetitive insertion
and internalization can reasonably be assumed to be continuous
processes as in the present model. A full set of A-Cell model and
parameter values are shown in Text S1. A simpler state transition
diagram was proposed in a previous report [24]. However, there is
a possibility that multiple pathways could contribute to the
formation and dissociation of a complex, and we could find no
reason to avoid some of them. In fact, high multimer complexes
such as M14D.M14D.T2.M2 and M14D.T2.M2.M14D.T2.M2
were formed shortly after the start of simulations (Figure S4 in
Text S1). Therefore, we employed the full set of possible state
transitions for MT1-MMP as shown in Figure 4B.
Simulation has shown the critical role of MT1-MMP
turnover for the degradation of ECM at invadopodia
In the absence of TIMP-2 the quadruple complex cannot be
formed, and in excess TIMP-2, the concentration of TIMP-2-free
MT1-MMP is reduced and proMMP-2 processing will be reduced
significantly. In both cases ECM degradation by activated MMP-2
will be reduced. The concentration of the MMP-2-ECM complex,
which is a measure of ECM degradation activity by MMP-2, was
maximum at a TIMP-2 concentration of 180 nM, and at both
higher and lower concentrations, it was steeply decreased as was
expected (Figure S5A in Text S1). In contrast, the concentration of
the MT1-MMP-ECM complex was maximum in the absence of
TMP-2, and it decreased gradually as the TIMP-2 concentration
increased (Figure S5B in Text S1). Since the concentration of the
MMP-2-ECM complex decreased very steeply, simulation of
ECM degradation was run at a TIMP-2 concentration of 180 nM.
Figure 3. Schematically illustrated model for a rapid turnover.
Two pools of MT1-MMP, pool X (PX) and pool D (PD), were assumed. In
pool X, insertion was dependent on the surface density of MT1-MMP,
and internalization proceeds at a constant rate. While in pool D,
insertion proceeds at a constant rate, and internalization was
dependent on the surface density.
doi:10.1371/journal.pcbi.1002479.g003
Figure 4. Outline of the model. (A) MT-MMPs in the membrane are dimerized, bound with TIMP-2, and activate proMMP-2. Any MT1-MMP, which
is TIMP-2-free, was assumed to degrade ECM. MT1-MMP and all of complexes were assumed to be internalized. (B) Complete diagram of interaction
between MT1-MMP, TIMP-2 and proMMP-2. Insertion is shown by a thick arrow for MT1-MMP, and internalization of MT1-MMP is shown in broken-
lined arrows with internalized species at small squares. MT1-MMP, TIP-2 and proMMP-2 are designated as M14, T2 and M2 for simplicity.
doi:10.1371/journal.pcbi.1002479.g004
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ECM-degradation rate (red), which is the amount of ECM-
degradation per unit time (mM/s). This is the sum of the
degradation rates by MT1-MMP and MMP-2 (i.e.
kfn11p*[M14X.fn]+kfn2p*[M2act.fn]+….. in the model). After the start
of ECM degradation, it is completely degraded at 600 s in the
control condition, where we used a turnover rate obtained from
the experiments.
If we changed the turnover rate of MT1-MMP by changing the
insertion (kX) and internalization (kD) time constants for pools X
and D, while keeping the surface concentration of MT1-MMP and
its complex constant, the degradation rate was changed. As shown
in Figure 5B, the ECM degradation became slow as the reduction
factor (small numbers) approached the state of no turnover. A
reduction factor of ten indicates one-tenth values of both kX and kD
at the same time.
Let the time to reach 50% degradation of ECM (th) be a measure
of the rate of ECM degradation. Smaller th values indicate a higher
rate of degradation. There was little change in th when the
reductionfactorwasbelowten(Figure 5C).When itwashigherthan
ten, however,th increasedconsiderably togetherwith theincrease in
the reduction factor. Thus the rate of ECM-degradation decreased
nonlinearly by the decrease in the turnover rate of MT1-MMP.
This indicates that the turnover rate of MT1-MMP is a critical
regulator of the ECM-degrading efficacy. The sensitivity analysis,
shown in Figure S6, indicated also that the turnover rate of MT1-
MMP is one of the sensitive parameters affecting th.
Next we sought the reason for the reduced ECM-degradation
that was associated with the reduced turnover rate of MT1-MMP.
We found that the ECM-degradation rate at a time point
corresponding to 50% ECM degradation was decreased by a
value corresponding to the increase in the reduction factor
(Figure 5D). In contrast, the concentration of inactivated MT1-
MMPs—which is the sum of the TIMP-2-occupied MT1-MMP
species such as MT1-MMP-TIMP-2, MT1-MMP-TIMP2-MT1-
MMP-TIMP2, or MT1-MMP-TIMP-2-MMP-2—increased con-
comitantly with the increase in the reduction factor. Thus the
decrease in the ECM degradation activity, which was caused by
the increase in the TIMP-2-occupied and inactivated MT1-MMP,
caused the increase in th by an increase in the turnover interval.
Figure 5. Simulation results of ECM degradation. (A) Simulated ECM degradation with the initial TIMP-2 concentration at 180 nM is shown as a
black line. Degradation rate, which is the rate of degradation in mM/s, is shown in red. (B) The time course of ECM degradation with several turnover
intervals. If the turnover interval is increased by the factors shown by small numbers, a longer time is required for the same degree of degradation,
reaching the state of no turnover (red curve). th is the time required to reach 50% degradation. (C) th increases concomitantly with an increase in the
reduction factor. There is a rapid increase in th when the reduction factor is increased tenfold or more. (D) Concomitantly with the increase in
reduction factor, the degradation rate (black) quickly decreases and stays almost unchanged at reduction factor increases larger than tenfold. In
contrast, the concentration of inactivated MT1-MMP complexes, which cannot degrade ECM or activate proMMP-2, is increased and reaches a plateau
level around a reduction factor of 10.
doi:10.1371/journal.pcbi.1002479.g005
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ECM both in experiments and spatiotemporal simulation
Activated MMP-2 is diluted by diffusion after it is released from
the MT1-MMP complex, and diffusing TIMP-2, which replen-
ishes free TIMP-2, increases the inhibition of MT1-MMP at the
site of its inhibition by TIMP-2. All these effects reduce ECM
degradation in a three-dimensional (3D) space. To visualize these
possibilities, we ran spatiotemporal simulations of ECM degrada-
tion (Figure S7 in Text S1). The extracellular space was divided
into small compartments allowing us to simulate reaction-diffusion
(see TextS1 for diffusion coefficient).
In the case with the MT1-MMP turnover observed in our
experiments, the ECM was greatly degraded at 800 s (upper panel
of Figure 6A). In the case of no turnover, however, no appreciable
ECM degradation was seen (lower panel of Figure 6A). This is
clearly seen by the time course shown in Figure 6B. Although a
small fraction of ECM was degraded during the first 500 s, no
appreciable ECM degradation took place between 500 s and
2,000 s. Thus, rapid turnover of MT1-MMP at invadopodia, as
found in our experiments at invadopodia is essential for the
effective ECM degradation seen in our simulation. The essential
role of rapid MT1-MMP turnover is also shown in experiments, in
which no appreciable ECM degradation was seen in the presence
of bafilomycin, Dynasore or Brefeldin A (Figure S1 in Text S1).
As shown in Figure S8 in Text S1, the relation between th and
the reduction factor in spatiotemporal simulations was comparable
with that shown in Figure 5C, and the relation of the degradation
rate and inactivated MT1-MMP complexes with the reduction
factor was similar to that shown in Figure 5D.
Simultaneous reduction of the turnover rate and the
concentration of MT1-MMP resulted in synergetic
reduction in ECM degradation
As a reduction in the concentration of MT1-MMP will also lead
to a reduced ECM degradation, we asked what would be more
effective for the reduction in ECM degradation, a reduced
turnover rate or the concentration of MT1-MMP As shown in
Figure 7, we found that the reduction in the MT1-MMP
concentration (conc.) was more effective in the reduction of
ECM-degradation than a decreased turnover rate (turnover). The
degradation efficacy was defined by 1/th. It is interesting,
however, that if we reduced the turnover rate and the
concentration of MT1-MMP at the same time (turnover+conc.),
a nonlinearly large and synergetic reduction in the degradation
efficacy was observed. While the separate reductions of the
turnover rate and the concentration of MT1-MMP to a reduction
factor of 10 resulted in the reduced degradation efficacies of 29.4%
and 17.7%, respectively, the simultaneous reduction resulted in
the degradation efficacy of 2.30% of the control value.
Discussion
Here we have revealed a rapid turnover of the surface MT1-
MMP with time constants of 26.0 and 259 s at invadopodia by
experiments. In addition, we have demonstrated both by
experiments and simulations that ECM degradation was blocked
by blocking of the rapid turnover of MT1-MMP. Thus we have
revealed a critical role of the rapid turnover for the effective ECM
degradation at invadopodia (Figure S9 in TextS1). Furthermore,
we have shown in simulations that simultaneous reductions in the
turnover rate and the vesicular content of MT1-MMP reduced the
ECM degradation synergistically by simulations. It has been
reported that invadopodia-associated actin comets represented a
biphasic recovery in FRAP signals: the initial fast recovery (15–
20 s) followed by a second slow recovery which reached a plateau
Figure 6. Simulation results for spatiotemporal model. (A)
Simulated degradation of ECM. With rapid turnover, MT1-MMP causes
degradation of ECM (top panel), while in its absence, no appreciable
ECM degradation is seen (bottom panel). (B) The time course of ECM
degradation in the absence and presence of the turnover of MT1-MMP.
The importance of the turnover for the effective degradation of ECM is
clearly seen.
doi:10.1371/journal.pcbi.1002479.g006
Figure 7. Reduction in the ECM-degradation efficacy by a
reduced turnover rate and/or reduced concentration of MT1-
MMP. The degradation efficacy is defined as 1/th and plotted as
normalized values at the control condition (reduction factor=1). A
larger degradation efficacy indicates a faster degradation of ECM. At the
same reduction factor, the reduction in degradation efficacy was higher
for a reduced concentration (conc.) than for a reduced turnover rate
(turnover). If both were reduced simultaneously, however, an unex-
pectedly larger reduction in the ECM reduction was observed
(turnover+conc.).
doi:10.1371/journal.pcbi.1002479.g007
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constants with those for the FRAP signal in the present report.
ECM degradation at invadopodia provides room for initial
protrusions. Further degradation provides additional space for the
elongation and enlargement of invadopodia. These processes are
thought to finally lead to the invasion of cancer cells [6,26,27].
There is a clear evidence for the involvement of MT1-MMP in
these processes [7,8,13]. On the other hand, MT1-MMP-
containing vesicles trafficking and fusing to the plasma membrane
were shown to be important for the ECM degradation [12], and
inhibited or decreased ECM degradation by drugs that block
vesicle transport has been reported [14,28,29]. Our present study
presents data supporting the involvement of the rapid turnover of
MT1-MMP for the initial stage of invasion.
Since rapid delivery of vesicles carrying MT1-MMP to
invadopodia is important for the ECM degrading activity, it is of
particular interest how this delivery process is regulated.
Bafilomycin inhibits acidification of lysosomes. Therefore, MT1-
MMP appears to be immediately delivered to invadopodia via an
endosome-lysosome pathway rather than by the Golgi apparatus
to the plasma membrane, which is preferentially inhibited by
brefeldin. Indeed, Steffen et al. reported that VAMP7, which
associates with late endosome-lysosome vesicles and plays a role in
membrane fusion, is required for MT1-MMP delivery to
invadopodia and regulates invadopodia formation by supporting
MT1-MMP-mediated ECM degradation. Colocalization of MT1-
MMP-mCherry with GFP-VAMP7 at invadopodia accompanying
ECM degrading was demonstrated [14].
The internalization of ErbB receptors (ErbBRs) has been
extensively studied, and its rate constant was reported to be in
the range of 0.04–0.2/min depending on the ligand-occupancy
[30,31]. In contrast, the recovery of fluorescence signal from
MT1-MMP proceeded with time constants of 26.0 and 259 s in
our study. From these values, we estimated an internalization rate
for pools D of 2.31/min (=60 s/26.0 s), which is one-order of
magnitude higher than that of ErbBRs. The internalization rate
for transferrin receptor was reported to be around 1/min [30,31].
We have shown a more than twofold higher rate for MT1-MMP.
Such a rapid turnover of MT1-MMP at invadopodia is
presumably critical for MT1-MMP to degrade ECM because
MT1-MMP is inactivated rapidly by TIMP-2 as shown in our
simulation results.
Endocytosis of receptors has been recognized as a mechanism
for their down-regulation. For example, ErbB receptors are known
to be internalized upon ligand binding, and this process down-
regulated receptor activity [32]. In the present model, however,
the internalization of MT1-MMP in pool X increased the ECM-
degrading activity by offering free sites for the insertion of new
MT1-MMP onto the membrane surface. Thus the internalization
of MT1-MMP can provide the opposite effect to that of ErbBR. If
the renewal of the surface MT1-MMPs was blocked, the
concentration of inactivated MT1-MMP increases by binding of
TIMP-2 as shown in Figures 6D and Figure S8B in Text S1. This
blocks both binding of MT1-MMP to ECM proteins and
activation of proMMP-2. Both of these effects will lead to a
decreased ECM degradation. Therefore, we conclude that the
rapid turnover and repetitive insertion of surface MT1-MMP is a
basis for the effective ECM degradation at invadopodia.
In our model we assumed the existence of pools X and D with
different insertion and internalization mechanisms for MT1
MMP. However, the observed fluorescence recovery with two
time constants can be explained by two pools D or two pools X.
Nevertheless, our bafilomycin experiments indicated the existence
of different mechanism for the two time-constant processes.
Therefore we assumed different insertion and internalization
mechanisms for pools X and D.
Mathematical models showing cancer cell invasion of tissue
have been reported previously [33,34,35]. One of the main
interests in these models is in the invasive behavior of a population
of cells. Our model, as presented in this work, focuses on the
invasive behavior of a subcellular structure, invadopodia. These
two approaches are different both in spatial and temporal scales.
The consolidation of the two approaches will be a challenge that
will be approached in the near future.
Here we have found a rapid turnover of surface MT1-MMP at
invadopodia with a time constant of 26.0 s. The reduction in the
turnover rate according to both fast and slow time constants
reduced the rate of ECM degradation as shown in Figures 5 and 6.
In addition, with simultaneous reductions in both the turnover rate
and the concentration of MT1-MMP, nonlinear and marked
reduction in the ECM degradation was seen in our simulations
(Figure 7). Thus, the rate of the turnover may be a critical
therapeutical parameter in addition to the inhibition of MT1-
MMP. The suggested combination treatment derived from our
mathematical model may make it possible to inhibit invadopodia-
mediated invasion selectively compared to other suggested
interventions.
Materials and Methods
Cell culture
The SCC61 cell lines have been described previously [10]. Cells
were maintained in DMEM with 20% fetal bovine serum with
0.4 mg/ml hydrocortisone.
Invadopodia assay
The matrix degradation assay was done as described by Chen et
al. Briefly, fibronectin (BD Biosciences) was labeled with Dylight
633 (Fisher) by dialysis in borate buffer [0.17 mol/L borate,
0.075 mol/L NaCl (pH 9.3)]. The buffer was changed to PBS and
dialyzed extensively for 3 to 4 days. To coat MatTek dishes, 2.5%
gelatin/2.5% sucrose in PBS added to the dish, followed by
crosslinking with 0.5% glutaraldehyde in PBS. 50 ug/mL solution
of fluorescence-labeled fibronectin was incubated with the cross-
linked gelatin in MatTek dishes in the dark for 1 h. The dish was
sterilized with 70% ethanol, washed with PBS, and equilibrated
with invadopodia medium [DMEM supplemented with 15% FBS
and 5% Nu-Serum (BD)] for 30 min before the addition of cells.
For invadopodia assays, 7610
4 cells were suspended in 2 mL of
invadopodia medium containing 100 uM EGF and added to the
plate for 18 h (parental cells) or 5 h (MT1-Luo cells).
Confocal photobleaching experiments
A combination of both FRAP and continuous photobleaching
techniques was developed on a confocal laser-scanning microscope
Nikon A1 microscope using Nice elements Software (Nikon).
MT1-Luo cells cultured on Dylight 633 labeled fibronectin for
5 hours were then bleached and scanned at two different regions
of interest (Region 1 and 2) using bleaching laser excitation
settings. During the bleaching phase, the region 1 (FRAP region)
was excited with regular imaging settings, whereas continuous
bleaching settings were used at the continuous photobleaching
region.
Cells were imaged using an inverted confocal laser-scanning
microscope (LSM 510, Carl Zeiss MicroImaging). The 488-nm
line of an argon laser was used to excite phLuorin. For all samples,
a Zeiss Plan-Neofluar 63X/1.3 oil immersion lens was used for
imaging. FRAP experiments were performed at room tempera-
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ROIs. Within the squares were photobleached for either 100 or
200 scan iterations using 100% transmission of the 488-nm-
wavelength laser.
Construction of computational model
The models were constructed using A-Cell [36,37], which can
be downloaded from http://www.ims.u-tokyo.ac.jp/mathcancer/
index.html. The models for pools X and D comprise interaction
between MT1-MMP with TIMP-2 and formation of ternary
complex (MT1-MMP-TIMP-2-MMP-2), internalization and in-
sertion of MT1-MMP, proMMP-2 activation by MT1-MMP,
MMP-2 inactivation by TIMP-2, and ECM degradation by MT1-
MMP and MMP-2. Biochemical reaction schemes were embed-
ded into the three-dimensional shape, as a model for the
degradation of ECM. Details of the model and parameter values
are shown in the Table S1 in Text S1, and can be downloaded
from the same site as the A-Cell download. In the A-Cell model,
MT1-MMP, TIMP-2, and MMP-2 were designated as M14, T2,
and M2 for simplicity.
Simulations
A reaction-diffusion simulation program in C language was
automatically generated by A-Cell from the constructed model,
and compiled using Intel C++ Studio XE 2011 for Linux. The
differential equations were numerically integrated by the fourth-
order Runge-Kutta method. Simulations were run on a Linux-
based system with Intel Xeon X5680 3.33 GHz.
Supporting Information
Text S1 Supplement figures S1, S2, S3, S4, S5, S6, S7, S8, S9
with legends, and texts for ‘‘Mathematical reconstruction of FRAP
signals’’, and ‘‘Detail of the Model’’.
(PDF)
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